135 related articles for article (PubMed ID: 20436300)
21. Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.
Walker M; Black EJ; Oehler V; Gillespie DA; Scott MT
Oncogene; 2009 Jun; 28(24):2314-23. PubMed ID: 19421147
[TBL] [Abstract][Full Text] [Related]
22. Ku affects the CHK1-dependent G(2) checkpoint after ionizing radiation.
Wang X; Li GC; Iliakis G; Wang Y
Cancer Res; 2002 Nov; 62(21):6031-4. PubMed ID: 12414624
[TBL] [Abstract][Full Text] [Related]
23. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
[TBL] [Abstract][Full Text] [Related]
24. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
[TBL] [Abstract][Full Text] [Related]
25. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
[TBL] [Abstract][Full Text] [Related]
26. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.
Yan Y; Black CP; Cowan KH
Oncogene; 2007 Jul; 26(32):4689-98. PubMed ID: 17297454
[TBL] [Abstract][Full Text] [Related]
27. Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation.
Chou YH; Ho YS; Wu CC; Chai CY; Chen SC; Lee CH; Tsai PS; Wu CH
Food Chem Toxicol; 2007 Aug; 45(8):1356-67. PubMed ID: 17329004
[TBL] [Abstract][Full Text] [Related]
28. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A
Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638
[TBL] [Abstract][Full Text] [Related]
29. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
30. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex.
Kim KS; Heo JI; Choi KJ; Bae S
Cancer Biol Ther; 2014; 15(12):1622-34. PubMed ID: 25535897
[TBL] [Abstract][Full Text] [Related]
32. Basis for the checkpoint signal specificity that regulates Chk1 and Cds1 protein kinases.
Brondello JM; Boddy MN; Furnari B; Russell P
Mol Cell Biol; 1999 Jun; 19(6):4262-9. PubMed ID: 10330167
[TBL] [Abstract][Full Text] [Related]
33. Active sites of human MEPE-ASARM regulating bone matrix mineralization.
Minamizaki T; Sakurai K; Hayashi I; Toshishige M; Yoshioka H; Kozai K; Yoshiko Y
Mol Cell Endocrinol; 2020 Nov; 517():110931. PubMed ID: 32712387
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis.
Jin ZH; Kurosu T; Yamaguchi M; Arai A; Miura O
Oncogene; 2005 Mar; 24(12):1973-81. PubMed ID: 15674326
[TBL] [Abstract][Full Text] [Related]
35. Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.
Ziegler V; Albers A; Fritz G
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1082-92. PubMed ID: 26876155
[TBL] [Abstract][Full Text] [Related]
36. p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors.
Petersen L; Hasvold G; Lukas J; Bartek J; Syljuåsen RG
Cell Prolif; 2010 Aug; 43(4):365-71. PubMed ID: 20590661
[TBL] [Abstract][Full Text] [Related]
37. DNA damage induces Chk1-dependent centrosome amplification.
Bourke E; Dodson H; Merdes A; Cuffe L; Zachos G; Walker M; Gillespie D; Morrison CG
EMBO Rep; 2007 Jun; 8(6):603-9. PubMed ID: 17468739
[TBL] [Abstract][Full Text] [Related]
38. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
Pan Y; Ren KH; He HW; Shao RG
Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
[TBL] [Abstract][Full Text] [Related]
40. NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint.
Melixetian M; Klein DK; Sørensen CS; Helin K
Nat Cell Biol; 2009 Oct; 11(10):1247-53. PubMed ID: 19734889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
